Patents by Inventor Frederick J. Lakner

Frederick J. Lakner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods related to fatty amino acid derivatives
    Patent number: 7439250
    Abstract: The present invention concerns the use of methods and/or compositions related to the synthesis and use of fatty asparagine, cysteine and/or serine derivatives. In particular, the invention concerns methods and compositions for the production of liposomes including fatty asparagine, cysteine and/or serine derivatives.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: October 21, 2008
    Assignee: Board of Regents, The University of Texas System
    Inventors: Frederick J. Lakner, George R. Negrete
  • Compounds to treat diabetes and associated conditions
    Patent number: 6855732
    Abstract: Compounds are provided that lower blood glucose concentrations, lower serum triglyceride concentrations, lower systolic blood pressure, and increase glucose uptake by adipose tissue, but do not affect the expression of PPAR-? by adipose tissue.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: February 15, 2005
    Assignee: Theracos, Inc.
    Inventors: Partha Neogi, Bishwajit Nag, Frederick J. Lakner, Debendranath Dev, Satyanarayana Medicherla
  • Compositions and methods related to fatty amino acid derivatives
    Publication number: 20040192894
    Abstract: The present invention concerns the use of methods and/or compositions related to the synthesis and use of fatty asparagine, cysteine and/or serine derivatives. In particular, the invention concerns methods and compositions for the production of liposomes including fatty asparagine, cysteine and/or serine derivatives.
    Type: Application
    Filed: November 17, 2003
    Publication date: September 30, 2004
    Applicant: Board of Regents, The university of Texas System
    Inventors: Frederick J. Lakner, George R. Negrete
  • Compounds to treat diabetes and associated conditions
    Patent number: 6525093
    Abstract: Compounds are provided that lower blood glucose concentrations, lower serum triglyceride concentrations, lower systolic blood pressure, and increase glucose uptake by adipose tissue, but do not affect the expression of PPAR-&ggr; by adipose tissue.
    Type: Grant
    Filed: November 8, 1999
    Date of Patent: February 25, 2003
    Assignee: Calyx Therapeutics Inc.
    Inventors: Partha Neogi, Bishwajit Nag, Frederick J. Lakner, Debendranath Dey, Satyanarayana Medicherla
  • Novel compounds to treat diabetes and associated conditions
    Publication number: 20020107285
    Abstract: Compounds are provided that lower blood glucose concentrations, lower serum triglyceride concentrations, lower systolic blood pressure, and increase glucose uptake by adipose tissue, but do not affect the expression of PPAR-&ggr; by adipose tissue.
    Type: Application
    Filed: February 15, 2002
    Publication date: August 8, 2002
    Applicant: Calyx Therapeutics, Inc.
    Inventors: Partha Neogi, Bishwajit Nag, Frederick J. Lakner, Debendranath Dev, Satyanarayana Medicherla
  • Alpha-arylated cinnamic esters and 1,4-bis(alpha-carboxyl-beta-styryl)benzene esters an UV-blocking agents
    Patent number: 6413504
    Abstract: Compounds of the structure wherein R and R′ are H, alkyl or aryl and each Z, X, Y and X′ is H, acylamino, acyloxy, alkanoyl, alkoxycarbonyl, amino, alkyl, alkoxy, hydroxy, alkylamino, dialkylamino, arylamino, alkylaryl, diarylamino, halo, carboxyl or cyano; and Z can also be are effective UV blockers.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: July 2, 2002
    Assignee: Calyx Therapeutics, Inc.
    Inventors: Frederick J. Lakner, Bishwajit Nag, Partha Neogi